Title : Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

Pub. Date : 2010 Oct

PMID : 20973802






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, the clinical use of FASN inhibitors, such as cerulenin, C75, and epigallocatechin 3-gallate (EGCG), is limited by anorexia and induced body weight loss or by its low in vivo potency and stability. Cerulenin fatty acid synthase Homo sapiens